Details of the Drug Reposition

General Information of This Drug (ID: DMZCG91)

Drug Name	CSL-112 DMZCG91
Synonyms	Reconstituted HDL (acute coronary syndrome), CSL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Cardiovascular disease	DIS2IQDX	BA00-BE2Z	Phase 2	[1]
Arteriosclerosis	DISK5QGC	BD40	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02108262) A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.. U.S. National Institutes of Health.